Aegon’s McPartlin: Three stocks driving the paradigm shift in healthcare
Exciting developments are underway in the healthcare world, and these three companies are leading that change
Exciting developments are underway in the healthcare world, and these three companies are leading that change
Antidiabetic drugs such as Ozempic have markets excited about healthcare, but AllianceBernstein’s Vinay Thapar calls for caution amongst the hype
Catherine Tennyson joins from Point 72 Asset Management
Demand for GLP-1 medications is skyrocketing
The sector looks set to thrive again this year after a strong 2023, but there is more to tech than just AI
The global equity team discusses AI, the energy transition, global travel and healthcare efficiency
European equity funds bruised by global manufacturing slowdown
The new offering aims to outperform the MSCI World Health Care Index
Stonehage Fleming’s Gerrit Smit discusses the fourth industrial revolution, the reopening of China and currency movements
Polar Capital’s Deane Donnigan tells Portfolio Adviser how she moved from clinical pharmacist to fund manager
Manager of the PGIM Jennison Global Equity Opportunities Fund discusses how last year’s valuation reset has created a more fertile hunting ground for equities
Pictet Positive Change manager Evgenia Molotova and her team look to identify companies with the skill, balance sheet and will to change